-
Abstract Number: 0645
Mortality and Ethnicity in Adults with Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Analysis
-
Abstract Number: 0646
Chart Audit of over 1,000 SLE Patients Reveals Biologic Treatment Choice Driven by Disease Manifestations
-
Abstract Number: 0647
Clinical Associations and Outcomes of Pericarditis in Systemic Lupus Erythematosus
-
Abstract Number: 0648
Prevalence of Pulmonary Complications Among Patients with Systemic Lupus Erythematosus (SLE): A Systematic Review and Meta-analysis
-
Abstract Number: 0649
Urinary Acetylated Albumin as a Biomarker of Nephritis in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 0650
Tubulointerstitial Inflammation Predicts Tubular Atrophy, Fibrosis, and Renal Function Loss in Lupus Nephritis
-
Abstract Number: 0651
Renal Survival and Mortality in Patients with Proliferative and Membranous Lupus Nephritis
-
Abstract Number: 0652
Analysis of Relapses in a Single Center Cohort of Patients with Lupus Nephritis
-
Abstract Number: 0653
Impact of Lupus Nephritis on Neuropsychiatric SLE Outcomes
-
Abstract Number: 0654
Corneal Confocal Microscopy: An Ophthalmic Imaging Biomarker for Small Fiber Neuropathy in Systemic Lupus Erythematosus
-
Abstract Number: 0655
Relationship Between Patient-Reported Outcomes to Hospitalization in Patients Living with SLE: A Retrospective Cohort Study Utilizing the FORWARD Lupus Registry
-
Abstract Number: 0656
Lupus Myocarditis: Clinical Characteristics, Cardiac Magnetic Resonance Imaging Findings and Outcomes
-
Abstract Number: 0657
Data-driven Bayesian Network Analysis for Predicting Difficult-to-treat (DTT) Lupus Nephritis
-
Abstract Number: 0658
Zetomipzomib (KZR-616), a First-in-Class Selective Immunoproteasome Inhibitor, Demonstrated Improvements in SLE/LN Disease Measures and Biomarkers in Patients with Highly Active SLE or Nephrotic Range Proteinuria in the Open-label Phase 1b/2 MISSION Study
-
Abstract Number: 0659
Obinutuzumab Benefits Patients with Active Lupus Nephritis Irrespective of Baseline Proteinuria Severity: A Post Hoc Analysis of a Phase II Trial
- « Previous Page
- 1
- …
- 43
- 44
- 45
- 46
- 47
- …
- 181
- Next Page »